In the early progressors, the RFX-mediated upregulation of identified HLA genes and MHC-associated pathways may confirm a pre-existing inflammatory condition and an already exhausted immune system, unable to inhibit melanoma spread. The gene discussed is HLA-C; the disease is melanoma.